Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
about
Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritisDendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic miceTumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model.Poxvirus interleukin-4 expression overcomes inherent resistance and vaccine-induced immunity: pathogenesis, prophylaxis, and antiviral therapy.Anticytokine therapy for osteoarthritis.High-efficiency gene transfer into nontransformed cells: utility for studying gene regulation and analysis of potential therapeutic targets.Cytokines in immunotherapy of experimental uveitis.Gene transfer approaches for the treatment of inflammatory bowel disease.Gene therapy for arthritis.Perspectives on the use of gene therapy for chronic joint diseases.Gene transfer as a future therapy for rheumatoid arthritis.Antigen-specific tolerogenic dendritic cells ameliorate the severity of murine collagen-induced arthritis.Gene therapy for autoimmune diseases: quo vadis?IL-4/CCL22/CCR4 axis controls regulatory T-cell migration that suppresses inflammatory bone loss in murine experimental periodontitisTherapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models.Regulation and function of epithelial secreted phospholipase A2 group X in asthma.Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling.Molecular targeting of hepatocyte growth factor by an antagonist, NK4, in the treatment of rheumatoid arthritis.Effector T cells in rheumatoid arthritis: lessons from animal models.Gene Therapy for Cartilage Repair.The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.Effects of scrocaffeside A from Picrorhiza Scrophulariiflora on immunocyte function in vitro.Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis.Innate immune response after adenoviral gene delivery into skin is mediated by AIM2, NALP3, DAI and mda5.Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis.The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen.Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis.StarPEG-Heparin Hydrogels to Protect and Sustainably Deliver IL-4
P2860
Q24796801-A3753D8E-C604-4DF1-80C5-BCB1F482A4B5Q28366650-A0908C61-CF20-4293-BF75-A7CE37570100Q33649618-AEF250B9-28A2-41B9-A326-15B2E4BC2546Q33988424-D32AACB7-90B5-4E22-B340-2738C670584BQ34432037-BF85FAF9-B073-4D7F-A0AB-18262A02CF4DQ34452635-D9F72E0B-2FD1-4A05-A616-D8A99FFF9DD7Q34731216-DA0D31CC-BB33-4EE6-AE5A-026AB43B87F1Q34993224-95050DF0-57E8-4CEA-8C2A-AA331FC84501Q35122162-4D7A9628-E900-403D-9A4E-81FA86C2391AQ35122176-53BE8040-A094-4B91-9753-726D42297986Q35151031-825A0F71-6B5B-4655-AE89-4C1AD125F1EDQ35164793-1334D6FF-316E-4A62-B357-3700311C6980Q35672805-B5A72B81-2F27-452F-A2E3-C71AFF063C54Q35906093-E75262A3-4D43-46C8-99C3-2CE40659C467Q35972520-225E0FD8-61A1-49D6-B5DF-B2105D7B4D1AQ36379002-64DF40D2-24EA-48AC-8C3A-FF1FAA22752EQ37074836-98093E95-5932-4295-ACCD-4163000E97DCQ37104028-97B5AA7D-9310-4FAD-8CAF-DF4C4C1B4389Q37690149-E41695BB-295F-4822-A7BA-945C3E4643B6Q37868325-34488632-833E-4BE7-9ABA-C1DBD683576AQ38526206-0C0056E1-22C6-4066-9AC1-55DD4F2B7F31Q39726638-561785F1-A37A-4B6A-8483-E2808BA8888FQ39953906-7626C32C-5C4C-4A7D-9F10-254B3D623F06Q40718956-E9523B5C-1EAA-426F-8D6B-0BBAF98A110FQ41453719-3750561A-A170-4628-8A80-1357164E20DDQ42824694-4B818EDA-2395-431C-8936-72E2649F9774Q44301754-7AF6ECFF-213D-45F5-9F6E-EF240D130720Q45869577-B0C481C5-FF4D-4BCB-8174-7E4544B8643DQ45883065-4F957C80-62A7-46E1-9C28-E6F437CD23F2Q51061290-A743FB3E-437E-4445-B4B1-5F845366E3DF
P2860
Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Gene therapy for established m ...... ated delivery of interleukin-4
@ast
Gene therapy for established m ...... ated delivery of interleukin-4
@en
Gene therapy for established m ...... ated delivery of interleukin-4
@nl
type
label
Gene therapy for established m ...... ated delivery of interleukin-4
@ast
Gene therapy for established m ...... ated delivery of interleukin-4
@en
Gene therapy for established m ...... ated delivery of interleukin-4
@nl
prefLabel
Gene therapy for established m ...... ated delivery of interleukin-4
@ast
Gene therapy for established m ...... ated delivery of interleukin-4
@en
Gene therapy for established m ...... ated delivery of interleukin-4
@nl
P2093
P2860
P921
P356
P1476
Gene therapy for established m ...... ated delivery of interleukin-4
@en
P2093
P2860
P2888
P304
P356
10.1186/AR104
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1049325650